The biotech industry is notorious for its pop-and-drop nature, but it also offers opportunities for risk-tolerant investors. For instance, these three companies' stock prices have tumbled, and one could be worth buying.

In the following slideshow I explain why these high-flying biotech companies are losing some of their luster and whether investors should consider buying them, holding them, or selling them.